E-LIB Suche - Ergebnisse für: Gilabert-Oriol, Roger - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

An unusual type I ribosome-inactivating protein from Agrost..:

Weise, Christoph ; Schrot, Achim ; Wuerger, Leonie T. D....
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

2

Liposomal OTS964, a TOPK inhibitor: a simple method to esti..:

Gilabert-Oriol, Roger ; Sutherland, Brent W. ; Anantha, Malathi..
Drug Delivery and Translational Research. 9 (2019) 6 - p. 1082-1094 , 2019

Link: https://doi.org/10.1007/..

3

Recent Treatment Advances and the Role of Nanotechnology, C..:

Chen, Kent T. J. ; Gilabert-Oriol, Roger ; Bally, Marcel B..
Pharmaceutical Research. 36 (2019) 9 - p. , 2019

Link: https://doi.org/10.1007/..

4

Developing liposomal nanomedicines for treatment of patient..:

, In: Lipid Nanocarriers for Drug Targeting,

Gilabert-Oriol, Roger ; Chernov, Lina ; Deyell, Rebecca J.. - p. 361-411 , 2018

Link: https://doi.org/10.1016/..

5

List of Contributors:

, In: Lipid Nanocarriers for Drug Targeting,

Ahmad, Muneer ; Ahmad, Mursalin ; Ali, Atif... - p. xix-xxii , 2018

Link: https://doi.org/10.1016/..

6

Liposomal Formulations to Modulate the Tumour Microenvironm..:

Gilabert-Oriol, Roger ; Ryan, Gemma M. ; Leung, Ada W.Y....
International Journal of Molecular Sciences. 19 (2018) 10 - p. 2922 , 2018

Link: https://doi.org/10.3390/..

7

In vitro assay for measuring real time topotecan release fr..:

Gilabert-Oriol, Roger ; Chernov, Lina ; Anantha, Malathi..
Drug Delivery and Translational Research. 7 (2017) 4 - p. 544-557 , 2017

Link: https://doi.org/10.1007/..

8

Unique therapeutic properties and preparation methodology o..:

Popov, Jesse ; Gilabert-Oriol, Roger ; Bally, Marcel B.
European Journal of Pharmaceutics and Biopharmaceutics. 117 (2017) - p. 256-269 , 2017

Link: https://doi.org/10.1016/..

9

A simple passive equilibration method for loading carboplat..:

Wehbe, Moe ; Malhotra, Armaan ; Anantha, Malathi...
Journal of Controlled Release. 252 (2017) - p. 50-61 , 2017

Link: https://doi.org/10.1016/..

10

Dianthin-30 or gelonin versus monomethyl auristatin E, each..:

Gilabert-Oriol, Roger ; Furness, Sebastian G. B. ; Stringer, Brett W....
Cancer Immunology, Immunotherapy. 66 (2017) 9 - p. 1217-1228 , 2017

Link: https://doi.org/10.1007/..

11

Augmenting the Efficacy of Immunotoxins and Other Targeted ..:

Fuchs, Hendrik ; Weng, Alexander ; Gilabert-Oriol, Roger
Toxins. 8 (2016) 7 - p. 200 , 2016

Link: https://doi.org/10.3390/..

12

Combinatorial approach to increase efficacy of Cetuximab, P..:

Gilabert-Oriol, Roger ; Weng, Alexander ; Trautner, Alexandra...
Biochemical Pharmacology. 97 (2015) 3 - p. 247-255 , 2015

Link: https://doi.org/10.1016/..

13

Electrophoretic mobility as a tool to separate immune adjuv..:

Gilabert-Oriol, Roger ; Weng, Alexander ; von Mallinckrodt, Benedicta...
International Journal of Pharmaceutics. 487 (2015) 1-2 - p. 39-48 , 2015

Link: https://doi.org/10.1016/..

14

Improved intracellular delivery of peptide- and lipid-nanop..:

Weng, Alexander ; Manunta, Maria D.I. ; Thakur, Mayank...
Journal of Controlled Release. 206 (2015) - p. 75-90 , 2015

Link: https://doi.org/10.1016/..

15

Reporter Assay for Endo/Lysosomal Escape ofToxin-Based Ther..:

Gilabert-Oriol, Roger ; Thakur, Mayank ; Von Mallinckrodt, Benedicta...
Toxins. 6 (2014) 5 - p. 1644-1666 , 2014

Link: https://doi.org/10.3390/..

1-15